SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

KOBO BIOTECH

BSE: 531541 30 Sep 2025
Commodities
₹ 2.4
KOBO BIOTECH LIMITED specializes in Commodity Chemicals within the Commodities sector.

KOBO BIOTECH - Share Price & Details

Market Cap
₹6.24
High /Low
4.62 / 2.48
Stock P/E
NA
Book Value
₹-55.8
Dividend Yield
0.0
ROCE
-52.9
ROE
₹NA
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹-150.0
Debt
140
CMP / FCF
0.17
Debt to equity
₹NA
NP Ann
-4.93
High price all time
72.0
Piotroski score
₹4.0
Graham Number
NA
No. Eq. Shares
2.38
Net CF
₹0.05
Net profit
-5.04
Price to book value
NA
Interest Coverage
₹NA
Low price all time
1.19
Industry PE
24.0
Reserves
₹-157
Free Cash Flow
₹0.20

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
SOUTHERN GAS LTD.NANANANA0.060.03
INDO GULF INDUSTRIES LTD.NANANANA0
KOBO BIOTECH LIMITEDNANANANA6.24
Avi Polymers Ltd.NANANANA5.757.19
SIMPLEX PAPERS LTD.NANANANA5.74

Peer Comparison Chart


About KOBO BIOTECH

KOBO BIOTECH LIMITED, with Security Code 531541, is a leading player in the Commodity Chemicals industry, categorized under the Commodities sector, offering Equity instruments.


Order Book


Latest News

Can Crop Life Science Limited Maintain Its Strong Profit Margins - Real-Time Stock Alerts & Free High Yield Portfolio Picks

(28 Sep 2025)
【Equity Trends】✌️ Professional-grade analytics and free investment tips in one platform.
Read more →

Can Procter Gamble Hygiene and Health Care Limited Maintain Growth Without Diluting Shareholders - Insider Selling Patterns & Lower Drawdowns With Smart Position Sizing

(28 Sep 2025)
【Stock Watchlist】✌️ Tap into global market momentum with up-to-date financial news, sector performance analysis, and high-potential stock...
Read more →

Should Value Investors Look at Ganga Pharmaceuticals Limited Stock Now - Stock Valuation Metrics & Free Rapid Profit Acceleration

(27 Sep 2025)
【Stock Highlights】✌️ We've helped thousands of investors, from beginners to veterans, identify winning stocks before they make headlines...
Read more →

Is KEYPRL a good long term investment - Stock Price Divergence & Double Digit Profit Strategies

(27 Sep 2025)
【Stock Trends】✌️ Whether you're trading daily or investing long-term, our platform provides data-driven stock forecasts that have...
Read more →

Kobo Biotech Hits New Low Amidst Broader Market Challenges and Declining Sales

(21 Sep 2025)
Kobo Biotech, a microcap in the commodity chemicals sector, has reached a new 52-week low, reflecting a year of underperformance.
Read more →

Kobo Biotech Faces Persistent Challenges Amid Broader Market Gains and Declining Sales

(17 Sep 2025)
Kobo Biotech has reached a new 52-week low, significantly underperforming its sector. The company has faced a challenging year,...
Read more →